Medical Devices Australia

Australia Pulsed Field Ablation Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia Pulsed Field Ablation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $22.4 Mn Placeholder estimate
Estimate 2025 $29.5 Mn 1.2% of the global market
Projected 2034 $354.4 Mn 1,100.2% Adds $324.9 Mn over 9 forecast years
CAGR 2025–2034 31.8% Faster than 99% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.16% of the global market.
  • In APAC, the largest is China at $178.0 Mn.
  • Fastest growing: India at 33.1% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$324.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Pulsed Field Ablation Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $22.4 Mn — —
2025 (base) $29.5 Mn +$7.1 Mn —
2026 (forecast) $38.9 Mn +$9.4 Mn +31.8%
2027 (forecast) $51.3 Mn +$12.4 Mn +73.7%
2028 (forecast) $67.6 Mn +$16.3 Mn +129%
2029 (forecast) $89.1 Mn +$21.5 Mn +201.8%
2030 (forecast) $117.5 Mn +$28.3 Mn +297.7%
2031 (forecast) $154.8 Mn +$37.3 Mn +424.2%
2032 (forecast) $204.0 Mn +$49.2 Mn +590.9%
2033 (forecast) $268.9 Mn +$64.9 Mn +810.6%
2034 (forecast) $354.4 Mn +$85.5 Mn +1,100.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Pulsed Field Ablation Market Analysis at a glance
Market size, 2025$29.5 Mn placeholder estimate
Forecast, 2034$354.4 Mn placeholder estimate
Growth (CAGR), 2025–203431.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersBoston Scientific Corporation, Medtronic, Johnson & Johnson, Abbott Laboratories, Kardium (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
Active clinical trials6 in AustraliaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Pulsed Field Ablation Market Analysis Executive Summary

Pulsed field ablation uses short electrical pulses to treat atrial fibrillation, damaging heart cells that cause the rhythm problem while sparing nearby tissue.

Key segments of the pulsed Field Ablation market include product (Catheters, Generators and Mapping Systems) and indication (Paroxysmal AF and Persistent AF).

Bar chart: Australia Pulsed Field Ablation market size, 2024–2034, placeholder estimates. $22.4 Mn in 2024, $29.5 Mn in 2025 and $354.4 Mn in 2034, 31.8% CAGR.
Australia Pulsed Field Ablation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Pulsed Field Ablation Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the pulsed Field Ablation market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the pulsed Field Ablation market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the pulsed Field Ablation market.

Competitive Landscape for Pulsed Field Ablation Market in Australia

The pulsed Field Ablation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pulsed Field Ablation Market in Australia

Pulsed Field Ablation in Australia: rules, payment and research

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2] ClinicalTrials.gov lists 6 studies on Pulsed Field Ablation that are recruiting, active or about to start in Australia.⁠[3] Early deaths from long-term diseases: 8.4% in 2023, the latest WHO figure for Australia.⁠[4]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how pulsed Field Ablation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pulsed Field Ablation right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pulsed Field Ablation in context

Australia compared

  • Early deaths from long-term diseases: 8.4% (2023). World: 17.2% (2023). 13th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[2]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Pulsed Field Ablation market in Australia?
Placeholder estimate: about $29.5 Mn in 2025, rising to about $354.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Pulsed Field Ablation market in Australia growing?
Placeholder estimate: about 31.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Pulsed Field Ablation market report cover?
The report splits the market by product (Catheters, Generators, Mapping Systems), indication (Paroxysmal AF, Persistent AF) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Pulsed Field Ablation market?
Key players include Boston Scientific Corporation, Medtronic, Johnson & Johnson, Abbott Laboratories and Kardium.
What is driving the Pulsed Field Ablation market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the pulsed Field Ablation market.
Who regulates Pulsed Field Ablation in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How many clinical trials on Pulsed Field Ablation are running in Australia?
6 studies are recruiting, active or about to start in Australia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
What does WHO report for Australia?
Early deaths from long-term diseases: 8.4% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in Australia are 65 or older?
18.1% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on cardiovascular

See the topic